Skip to main content
Log in

Defining Sarcopenia in the Indian Population—a Step Forward

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Decline in muscle mass and function has been associated with frailty syndrome and other chronic medical conditions. Poor outcomes following treatment have been reported in various gastrointestinal malignancies in sarcopenic patients. The Asian Working Group of Sarcopenia has suggested 2 standard deviation below the mean muscle mass of a young reference group, as the cut-off point for defining this entity. However, values vary according to ethnicities, and no study has previously assessed muscle indices in the Indian population. The study aims to access muscle area and density as markers of sarcopenia and to define sex specific cut off points for the Indian population. This is a prospective study conducted at the Medanta Hospital from May 2016 to March 2018. Prospective organ donors, in age group of 18 to 65 years, were enrolled in this study. Computed tomography scan of the abdomen (used for preoperative evaluation) was used to evaluate psoas muscle area and density at the level of transverse processes of the third and fourth lumbar vertebrae. Plain scan images with 3 mm cuts were used for calculations. Psoas area was normalized for height, and density was normalized for weight. Mean of psoas area (acquired at L3 and L4 levels) was normalized for height, and values less than 2 standard deviation (SD) below the mean were calculated. Similar calculations were done for psoas density. Values using 1.64SD below the mean, 5th percentile and 10th percentile were calculated as well. There were 457 healthy donors who were enrolled in the study, but 26 were excluded from the analysis as they belonged to non-Indian ethnicities. Sex-specific values were calculated. Values at 2SD below the mean, 1.64SD below the mean, 5th percentile and 10th percentile for the male population were 173.8 mm2/m2, 210.7 mm2/m2, 220.7 mm2/m2 and 239.05 mm2/m2, respectively, for psoas area. Similar values for psoas density were 0.48, 0.53, 0.56 and 0.575 Hounsfield units/kg, respectively. For the female cohort, values at 2SD below the mean, 1.64SD below the mean, 5th percentile and 10th percentile, for psoas density, were 101.2 mm2/m2, 128.7 mm2/m2, 149.5 mm2/m2 and 173.80 mm2/m2, respectively. Values for psoas density were 0.26, 0.36, 0.53 and 0.59 Hounsfield units/kg, respectively. 5th percentile values and values at 1.64SD below the mean were found to be more concordant, and we have decided to take 5th percentile values as the cut-off point to define sarcopenia for further studies. We defined sarcopenia at 5th percentile, with sex-specific cut-off points for psoas area and density. Defining this parameter is important as there has been a substantial increase in the elderly population. Studies have shown poor outcomes in patients with sarcopenia, when managing them for chronic illnesses and malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Image 1
Image 2
Fig. 1
Graph 1
Graph 2
Graph 3
Graph 4
Graph 5
Graph 6

Similar content being viewed by others

References

  1. Zhang G, Li X, Sui C, Zhao H, Zhao J, Hou Y et al (2016) Incidence and risk factor analysis for sarcopenia in patients with cancer. Oncol Lett 11(2):1230–1234

    Article  CAS  Google Scholar 

  2. Rosenberg IH (2011) Sarcopenia: origins and clinical relevance. Clin Geriatr Med 27(3):337–339

    Article  Google Scholar 

  3. Wagner D (2016) Role of frailty and sarcopenia in predicting outcomes among patients undergoing gastrointestinal surgery. World J Gastrointestinal Surg 8(1):27–40

    Article  Google Scholar 

  4. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39(4):412–423

    Article  Google Scholar 

  5. Chen L-K, Liu L-K, Woo J, Assantachai P, Auyeung T-W, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JSW, Lee WJ, Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, Suzuki T, Won CW, Wu CH, Wu SN, Zhang T, Zeng P, Akishita M, Arai H (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15(2):95–101

    Article  Google Scholar 

  6. Baumgartner R, Koehler K, Gallagher D, Romero L, Heymsfield S, Ross R et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763

    Article  CAS  Google Scholar 

  7. Marcell TJ (2003) Review article: sarcopenia: causes, consequences, and preventions. J Gerontol Ser A Biol Med Sci 58(10):M911–M916

    Article  Google Scholar 

  8. Sanada K, Miyachi M, Tanimoto M, Yamamoto K, Murakami H, Okumura S, Gando Y, Suzuki K, Tabata I, Higuchi M (2010) A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol 110(1):57–65

    Article  CAS  Google Scholar 

  9. Lau EMC, Lynn HSH, Woo JW, Kwok TCY, Melton LJ (2005) Prevalence of and risk factors for sarcopenia in elderly Chinese men and women. J Gerontol A Biol Sci Med Sci 60(2):213–216

    Article  Google Scholar 

  10. Kim TN, Yang SJ, Yoo HJ, Lim KI, Kang HJ, Song W, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM (2009) Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes 33(8):885–892

    Article  CAS  Google Scholar 

  11. Kim Y-S, Lee Y, Chung Y-S, Lee D-J, Joo N-S, Hong D, Song G, Kim HJ, Choi YJ, Kim KM (2012) Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol Ser A Biol Med Sci 67(10):1107–1113

    Article  Google Scholar 

  12. Christensen JF, Jones LW, Andersen JL, Daugaard G, Rorth M, Hojman P (2014) Muscle dysfunction in cancer patients. Ann Oncol 25(5):947–958

    Article  CAS  Google Scholar 

  13. Donohoe CL, Ryan AM, Reynolds JV (2011) Cancer cachexia: mechanisms and clinical implications. Gastroenterol Res Pract 2011:1–13

    Article  Google Scholar 

  14. Harimoto N, Shirabe K, Yamashita Y-I, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Maehara Y, Nishie A, Yamanaka T (2013) Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma: sarcopenia and outcome of hepatectomy for hepatocellular carcinoma. Br J Surg 100(11):1523–1530

    Article  CAS  Google Scholar 

  15. Pecorelli N, Carrara G, De Cobelli F, Cristel G, Damascelli A, Balzano G et al (2016) Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery: sarcopenia and visceral obesity in pancreaticoduodenectomy. Br J Surg 103(4):434–442

    Article  CAS  Google Scholar 

  16. Lodewick TM, Roeth AAJ, Olde Damink SWM, Alizai PH, van Dam RM, Gassler N, Schneider M, dello SAWG, Schmeding M, Dejong CHC, Neumann UP (2015) Sarcopenia, obesity and sarcopenic obesity: effects on liver function and volume in patients scheduled for major liver resection: sarcopenia, obesity and sarcopenic obesity. J Cachexia Sarcopenia Muscle 6(2):155–163

    Article  Google Scholar 

Download references

Acknowledgements

We are grateful to the Department of Liver transplantation and the Department of Urology for permitting us to use the data of their patients for this study.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study, and the manuscript has been approved by all authors.

Study conception and design: Adarsh Chaudhary, Deeksha Kapoor and Tarun Piplani

Acquisition of data: Deeksha Kapoor and Tarun Piplani

Analysis and interpretation of data: Deeksha Kapoor, Amanjeet Singh and Adarsh Chaudhary

Drafting of manuscript:Deeksha Kapoor, Adarsh Chaudhary, Amanjeet Singh and Azhar Perwaiz

Critical revision: Azhar Perwaiz, Amanjeet Singh and Adarsh Chaudhary

Corresponding authors

Correspondence to Deeksha Kapoor or Adarsh Chaudhary.

Ethics declarations

We the authors, Deeksha Kapoor, Tarun Piplani, Amanjeet Singh, Azhar Perwaiz and Adarsh Chaudhary, have obeyed and complied with ethical standards, with approval from ethics committee of our institute.

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethics Approval

This study was approved by the Institutional Review Board of the institution and the Ethics Committee of Medanta, the Medicity (Approval No. MICR – 638/2016). The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kapoor, D., Piplani, T., Singh, A. et al. Defining Sarcopenia in the Indian Population—a Step Forward. Indian J Surg 83, 476–482 (2021). https://doi.org/10.1007/s12262-020-02378-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-020-02378-6

Keywords

Navigation